ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 382053 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 382053; 2) Community: the network communities that were significantly associated with the response to NSC 382053; 3) Molecule: the relationships between components within communities and NSC 382053; 4) MDR: the compounds that were significantly associated with the NSC 382053.

NSC Compound Enrichment Correlation
NSC 749518 1-[(2Z)-3-amino-3-phenylprop-2-enoyl]-3-phenyl-1H-pyrazol-5-amine 0.03551961774939 0.36451584
NSC 752703 Null 0.03551961774939 0.5976866
NSC 753187 4-chloro-N-(4-(3-(4-chloro-3-methoxyphenyl)-4-(pyridin-4-yl)-1H-pyrazol-1-yl)phenyl)-3-(trifluoromethyl)benzamide 0.03551961774939 0.18458413
NSC 753734 7alpha-acetoxyroylenane 0.03551961774939 0.072014757
NSC 758845 Null 0.03551961774939 0.45341735
NSC 760015 E)-1-(4-(quinazolin-4-ylamino)phenyl)-3-(2,4,6-trimethoxyphenyl)prop-2-en-1-one 0.03551961774939 0.42240102
NSC 763564 EMD-534085 0.03551961774939 0.31191285
NSC 94945 Questiomycin A 0.03551961774939 0.18066496
NSC 622926 Null 0.0361455178924428 -0.15102525
NSC 647638 1,2-Dioxin-3-acetic acid, 3,6-dihydro-6-methoxy-6-(14,16- octadecadienyl)-, methyl ester, [3.alpha.,6.alpha.,6(14E,16E)]-(+)- (9CI) 0.0361455178924428 0.19960367
Total:136  Current:106    [First] [Prev] [Next] [Last]